Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

56.13
BATS BZX Real-Time Price
As of 1:19pm ET
 +0.36 / +0.65%
Today’s Change
46.01
Today|||52-Week Range
77.12
-3.95%
Year-to-Date
Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, No...
8:15am / Zacks.com - Paid Partner Content
Bristol Myers' Future Unsure as Carl Icahn Takes Stake
Feb 22 / Zacks.com - Paid Partner Content
Searle & Co. Buys Exxon Mobil, Bristol-Myers Squibb Company, Bank of Americaoration
7:47am / GuruFocus News - Paid Partner Content
Exelixis (EXEL) Q4 Earnings: Is Positive Surprise in Store?
Feb 22 / Zacks.com - Paid Partner Content
Company News for February 23, 2017
Feb 23 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb: grave dancing denied
Feb 22 / FT.com - Paid Partner Content
Cramer: Buyers for Bristol-Myers Are Few and Far Between
Feb 22 / TheStreet.com - Paid Partner Content
S&P 500 Trades Lower as Fed Signals Move on Rates 'Fairly Soon'
Feb 22 / TheStreet.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Dow Turns Positive in Wishy-Washy Trading Ahead of Fed Minutes
Feb 22 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close55.77
Today’s open55.98
Day’s range55.88 - 56.21
Volume324,371
Average volume (3 months)12,357,896
Market cap$93.3B
Dividend yield2.78%
Data as of 1:19pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)-0.91%
Earnings growth (next 5 years)+17.65%
Revenue growth (last year)+17.31%
P/E ratio28.1
Price/Sales5.05
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-1.90-1.59%
AGNAllergan-2.00-0.81%
LLYEli Lilly and Co+0.12+0.15%
ABBVAbbVie-0.03-0.05%
Data as of 1:19pm ET, 02/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.73
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts


Search for Jobs